Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
featured
Published in Oncology

Journal Scan / Research · October 12, 2022

Longitudinal Liquid Biopsy Anticipates Hyperprogression and Early Death From Advanced NSCLC Treated With ICIs

British Journal of Cancer

 

Additional Info

Disclosure statements are available on the authors' profiles:

British Journal of Cancer
Longitudinal liquid biopsy anticipates hyperprogression and early death in advanced non-small cell lung cancer patients treated with immune checkpoint inhibitors
Br. J. Cancer 2022 Sep 29;[EPub Ahead of Print], E Zulato, P Del Bianco, G Nardo, I Attili, A Pavan, A Boscolo Bragadin, L Marra, G Pasello, M Fassan, F Calabrese, V Guarneri, PF Conte, S Indraccolo, L Bonanno

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading